Feasibility of pooling sera for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and estimate HIV incidence

被引:117
作者
Quinn, TC
Brookmeyer, R
Kline, R
Shepherd, M
Paranjape, R
Mehendale, S
Gadkari, DA
Bollinger, R
机构
[1] Johns Hopkins Univ, Div Infect Dis, Sch Med, Baltimore, MD 21205 USA
[2] NIAID, Immunoregulat Lab, Bethesda, MD 20892 USA
[3] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Biostat, Baltimore, MD USA
[4] Natl AIDS Res Inst, Pune, Maharashtra, India
关键词
HIV incidence; serumsample pooling; p24 antigen assay; reverse transcriptase-polymerase chain reaction;
D O I
10.1097/00002030-200012010-00015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To develop a pooling method for detection of viral RNA for diagnosis of acute HIV infection and estimation of HIV-1 incidence. Methods: Sera from 700 consecutive seronegative patients attending sexually transmitted disease clinics in Pune, India, were screened individually for p24 antigen, and pooled into seven pools of 100 for detection of HIV-1 RNA by reverse transcriptase-polymerase chain reaction. HIV-1 incidence was calculated by the traditional cohort method, the p24 antigen method, and a multistage pooling method in which RNA-positive pools were re-analyzed in smaller pools. Results: Sera from 700 individuals were grouped into seven pools of 100, of which four were positive. These four positive pools were subdivided into eight pools of 50, of which seven were positive. The seven positive pools were subdivided into 35 pools of 10, of which 10 were positive. Based on the 10 RNA-positive pools, the point estimate of HIV-1 incidence was 19.9% per year [95% confidence interval (CI), 7.3-31.8%]. Of the 700 samples analyzed for p24 antigen, eight were positive, resulting in a point estimate of incidence of 18.5%/year (8.0-36.5%). In contrast, the incidence rate based on the traditional cohort method of follow-up was lower at 9.4%/year (4.8-16.4%) due to a low follow-up rate. Testing of individual samples from the 10 RNA-positive pools identified 10 individuals with acute primary HIV-1. Conclusion: The multistage pooling method for detection of HIV-1 RNA was more sensitive than the p24 antigen method, and was five-fold less expensive than the p24 antigen assays. Pooling samples for RNA detection was effective in estimating current incidence rates with cost savings that would be practical for use in developing countries. (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:2751 / 2757
页数:7
相关论文
共 33 条
[1]   SUCCESSFUL USE OF POOLED SERA TO DETERMINE HIV-1 SEROPREVALENCE IN ZAIRE WITH DEVELOPMENT OF COST-EFFICIENCY MODELS [J].
BEHETS, F ;
BERTOZZI, S ;
KASALI, M ;
KASHAMUKA, M ;
ATIKALA, L ;
BROWN, C ;
RYDER, RW ;
QUINN, TC .
AIDS, 1990, 4 (08) :737-741
[2]   Measuring HIV-1 incidence in northern Thailand: Prospective cohort results and estimates based on early diagnostic tests [J].
Beyrer, C ;
Brookmeyer, R ;
Natpratan, C ;
Kunawararak, P ;
Niraroot, V ;
Palapunya, P ;
Khamboonruang, C ;
Celentano, DD ;
Nelson, KE .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 12 (05) :495-499
[3]   Risk factors and clinical preservation of acute primary HIV infection in India [J].
Bollinger, RC ;
Brookmeyer, RS ;
Mehendale, SM ;
Paranjape, RS ;
Shepherd, ME ;
Gadkari, DA ;
Quinn, TC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (23) :2085-2089
[4]   Accounting for follow-up bias in estimation of human immunodeficiency virus incidence rates [J].
Brookmeyer, R .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY, 1997, 160 :127-140
[5]   Analysis of multistage pooling studies of biological specimens for estimating disease incidence and prevalence [J].
Brookmeyer, R .
BIOMETRICS, 1999, 55 (02) :608-612
[6]   ESTIMATION OF CURRENT HUMAN-IMMUNODEFICIENCY-VIRUS INCIDENCE RATES FROM A CROSS-SECTIONAL SURVEY USING EARLY DIAGNOSTIC-TESTS [J].
BROOKMEYER, R ;
QUINN, TC .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 141 (02) :166-172
[7]   THE AIDS EPIDEMIC IN INDIA - A NEW METHOD FOR ESTIMATING CURRENT HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INCIDENCE RATES [J].
BROOKMEYER, R ;
QUINN, T ;
SHEPHARD, M ;
MEHENDALE, S ;
RODRIGUES, J ;
BOLLINGER, R .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 142 (07) :709-713
[8]   TIME-COURSE OF DETECTION OF VIRAL AND SEROLOGIC MARKERS PRECEDING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SEROCONVERSION - IMPLICATIONS FOR SCREENING OF BLOOD AND TISSUE DONORS [J].
BUSCH, MP ;
LEE, LLL ;
SATTEN, GA ;
HENRARD, DR ;
FARZADEGAN, H ;
NELSON, KE ;
READ, S ;
DODD, RY ;
PETERSEN, LR .
TRANSFUSION, 1995, 35 (02) :91-97
[9]   Mini-pool screening by nucleic acid testing for hepatitis B virus, hepatitis C virus, and HIV: preliminary results [J].
Cardoso, MS ;
Koerner, K ;
Kubanek, B .
TRANSFUSION, 1998, 38 (10) :905-907
[10]   Direct and indirect estimates of HIV-1 incidence in a high-prevalence population [J].
Cleghorn, FR ;
Jack, N ;
Murphy, JR ;
Edwards, J ;
Mahabir, B ;
Paul, R ;
O'Brien, T ;
Greenberg, M ;
Weinhold, K ;
Bartholomew, C ;
Brookmeyer, R ;
Blattner, WA .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1998, 147 (09) :834-839